ArticleHeliyon2024

The efficacy and safety of the novel combination lenvatinib and pembrolizumab in endometrial cancer: A systematic review and single-arm meta-analysis.

Wania Sultan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.